Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: GQE1BJE2NI

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Integrin alpha-V/beta-3 antagonist PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Prostatic Neoplasms 2 D011471 ClinicalTrials
Melanoma 1 D008545 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 725735-28-4
ChEMBL CHEMBL1743032
FDA SRS GQE1BJE2NI